1.Toward precision medicine for preserving fertility in cancer patients: existing and emerging fertility preservation options for women.
So Youn KIM ; Seul Ki KIM ; Jung Ryeol LEE ; Teresa K WOODRUFF
Journal of Gynecologic Oncology 2016;27(2):e22-
As the number of young cancer survivors increases, quality of life after cancer treatment is becoming an ever more important consideration. According to a report from the American Cancer Society, approximately 810,170 women were diagnosed with cancer in 2015 in the United States. Among female cancer survivors, 1 in 250 are of reproductive age. Anticancer therapies can result in infertility or sterility and can have long-term negative effects on bone health, cardiovascular health as a result of reproductive endocrine function. Fertility preservation has been identified by many young patients diagnosed with cancer as second only to survival in terms of importance. The development of fertility preservation technologies aims to help patients diagnosed with cancer to preserve or protect their fertility prior to exposure to chemo- or radiation therapy, thus improving their chances of having a family and enhancing their quality of life as a cancer survivor. Currently, sperm, egg, and embryo banking are standard of care for preserving fertility for reproductive-age cancer patients; ovarian tissue cryopreservation is still considered experimental. Adoption and surrogate may also need to be considered. All patients should receive information about the fertility risks associated with their cancer treatment and the fertility preservation options available in a timely manner, whether or not they decide to ultimately pursue fertility preservation. Because of the ever expanding number of options for treating cancer and preserving fertility, there is now an opportunity to take a precision medicine approach to informing patients about the fertility risks associated with their cancer treatment and the fertility preservation options that are available to them.
Adult Stem Cells
;
Cell Culture Techniques
;
Cryopreservation/*methods
;
*Embryo, Mammalian
;
Female
;
Fertility Preservation/*methods
;
Humans
;
Neoplasms/drug therapy/*therapy
;
*Oocytes
;
Ovarian Follicle/drug effects/metabolism/transplantation
;
*Ovary/transplantation
;
Ovulation Induction/methods
;
Precision Medicine
2.The effect of danshen on the angiogenesis of the frozen-thawed human fetal ovarian tissue after transplantation.
Dan-dan WU ; Ying ZHOU ; Bing-sen XU ; Yue-hong TONG ; Lin-ju
Chinese Journal of Applied Physiology 2009;25(3):330-333
AIM(1) To investigate the mRNA expression of the key angiogenic growth factors in the grafts after transplantation. (2) To investigate the potential impact of danshen (Chinese traditional medicine) administration on grafts angiogenesis.
METHODSThe frozen-thawed ovarian tissue from aborted fetus were xenografted into the renal capsule of the nude mice, recovered 48 h, 7 d and 28 d after respectively. Either danshen or saline (as the control) was administered after transplantation.
RESULTSThe mRNA levels of VEGF showed a temporary raise in 48 h after transplantation, then decreased in one week, and no significant difference was fund between the control group and danshen group. Ang-2 was increased in 48 h after transplantation, when Danshen group was significantly higher than the control group (P < 0.05). The microvessel density significantly increased in all the tissues after transplantation. The control group peaked on day 7 after transplantation, while danshen group peaked in 48 h and kept correspondingly steady after that.
CONCLUSIONEarly angiogenesis began within 48 h after transplantation of the thawed human fetal ovarian tissue, and its microvessel density peaked within the first week after transplantation. Our results also suggested that the use of danshen injection in conjunction with transplantation could facilitate revascularization of the grafts.
Angiopoietin-2 ; genetics ; metabolism ; Animals ; Cryopreservation ; Drugs, Chinese Herbal ; pharmacology ; Female ; Fetal Tissue Transplantation ; methods ; Fetus ; Humans ; Mice ; Mice, Inbred BALB C ; Mice, Nude ; Neovascularization, Physiologic ; drug effects ; Ovarian Follicle ; cytology ; growth & development ; transplantation ; RNA, Messenger ; genetics ; metabolism ; Salvia miltiorrhiza ; chemistry ; Transplantation, Heterologous ; methods ; Vascular Endothelial Growth Factor A ; genetics ; metabolism